Physician profile
Carl Maltese
NPI 1487702999
$10,526.64
in general payments reported to CMS, 2019-2025
21 companies · $2,167 in 2025
The $2,167 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,844 · 2020: $1,001 · 2021: $1,583 · 2022: $1,092 · 2023: $1,017 · 2024: $1,821 · 2025: $2,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,005.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,610.17 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Boston Scientific Corporation | $2,497.65 | 2019-2025 | Varithena Administration Pack, Jetstream Sc, Eluvia |
| Penumbra, INC. | $2,424.20 | 2021-2025 | Indigo System, Smart Coil, Ruby Coil |
| Medtronic Vascular, INC. | $1,222.86 | 2019-2020 | |
| Abiomed | $428.93 | 2023-2025 | Impella |
| Getinge USA Sales, LLC | $387.73 | 2019-2022 | |
| Solventum Corporation | $129.90 | 2024 | Prevena |
| Baxter Healthcare | $128.57 | 2021-2025 | Preveleak |
| Cook Medical LLC | $125.02 | 2025 | Cook |
| Biocomposites INC | $114.14 | 2025 | Stimulan |
| Shape Memory Medical INC. | $100.78 | 2025 | Impede Embolization Plug |
| Atrium Medical Corporation | $81.54 | 2021 | |
| Atricure, INC. | $61.56 | 2024 | |
| Ethicon US, LLC | $50.00 | 2021 | |
| W. L. Gore & Associates, INC. | $38.16 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $34.27 | 2020 | |
| Abbott Laboratories | $24.82 | 2023 | Perclose Prostyle |
| Lemaitre Vascular, INC. | $20.08 | 2020 | |
| Kerecis Limited | $16.53 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| B. Braun Interventional Systems INC. | $15.20 | 2023 | Vena Tech |
| Chiesi USA, INC. | $14.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Maltese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.